Dr. John Murphy:

There are a number of parallel groups. We in the clinical lead programme in paediatrics and neonatology were contacted by the HSE to look into the matter. We are setting up a meeting shortly. We are bringing together a group of consultants and specialists who deal with children with these types of disorders and the relationship with Epilim to see what we should do to best progress things. We will meet in the next few weeks to try to progress things rapidly. I am aware there are a lot of issues and anxieties around it.